Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA drug recalls in 2021

Every FDA drug recall initiated in 2021, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.

1,152 recalls, newest first.

Class II · Moderate risk

Rybelsus (semaglutide)

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. NDC 0169-4307-13 D-0536-2021
Class II · Moderate risk

Proctofoam HC

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. NDC 0037-6822-10 D-0529-2021
Class II · Moderate risk

Belsomra (suvorexant)

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. NDC 0006-0335-30 D-0523-2021
Class II · Moderate risk

Belsomra (suvorexant)

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. NDC 00006-0033-30 D-0522-2021
Class II · Moderate risk

Pedia-Lax 66ml

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. D-0521-2021

Recalls by year